Archives for October 29, 2008

← 2008

FDA raps Bayer in ‘combo' product crackdown

By Shane Starling

In a move that has divided industry, the Food and Drug Administration (FDA) has told German pharma giant Bayer in no uncertain terms to cease making disease reduction claims about products that contain both pharmaceutical and nutraceutical ingredients.

Section 912 and the blurring of the supplement-drug line

By Lorraine Heller

The US Food and Drug Administration (FDA) yesterday said it is extending the comment period for Section 912 of its Amendments Act (FDAAA), which has the potential to radically change the way dietary supplements are regulated in the country.

What is Section 912?

Stuart Craig, Danisco's director of Regulatory and Scientific Affairs, North America, explains why Section 912 could have a major impact on the way dietary supplements are regulated in the United States.

Exploring the sweet future for stevia

As regulatory approval for stevia and its extracts gathers pace in the US, Mark Blumenthal from the American Botanical Council gives his thoughts and inside knowledge on his nominee for ‘herb of the year’.